Novartis cuts CCO title as international chief Marie-France

$ 16.50

4.6
(415)
In stock
Description

Just as Novartis’ C-suite appeared to have stabilized amid a major overhaul of the company, the Swiss pharma is losing its international markets leader and getting rid of its chief commercial offic | Just as Novartis’ C-suite appeared to have stabilized amid a major overhaul of the company, the Swiss pharma is losing its international markets leader and getting rid of its chief commercial officer title.

09.06.23 Novartis replaces outgoing exec, scraps CCO title; J&J's Rybrevant posts win in large lung cancer field - Questex

Novartis to cut up to 8,000 jobs globally

What's behind the Novartis job cuts? - SWI

Brain Tumour Magazine: World Edition 2021/2022 by The

Michael Meegan on LinkedIn: Novartis cuts top commercial title, replaces departing exec Marie-France…

Novartis job cuts to heavily impact management roles - SWI

Document

Brain Talks Podcast - Brain Innovation Days

Tschudin Facebook, Instagram & Twitter on PeekYou